Evidence map›Paper›PMID 41316455›Full record

ArticleJournal of medical case reports2025

Senior-Løken syndrome with IQCB1/NPHP5 mutation in an adult: a case report.

İrem Demirtas, Sibel Gökcay Bek

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

İrem DemirtasDepartment of Internal Medicine, Faculty of Medicine Hospital, Kocaeli University, Kocaeli, Türkiye.
Sibel Gökcay BekDepartment of Nephrology, Faculty of Medicine Hospital, Kocaeli University, Kocaeli, Türkiye. beksibel@gmail.com.ORCID http://orcid.org/0000-0003-3325-5993

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSenior-Løken syndrome is a rare autosomal recessive ciliopathy characterized by nephronophthisis and early-onset retinal dystrophy. It is typically diagnosed in childhood, and adult-onset diagnosis is rare and may delay renal-protective interventions. Here, we report a rare case of Senior-Løken syndrome in an adult with an IQCB1/NPHP5 mutation. CASE PRESENTATION: A 20-year-old Turkish male presented with rotatory nystagmus since birth, progressive visual impairment from childhood, and chronic kidney disease that began during adolescence. The patient exhibited polyuria and polydipsia, and the ocular electrophysiology results were consistent with retinitis pigmentosa. Initial laboratory results were as follows: hemoglobin 11.03 g/dL, urea 56.65 mg/dL, creatinine 2.59 mg/dL, estimated glomerular filtration rate 34.14 mL/min/1.73 m

conclusionChronic kidney disease in Senior-Løken syndrome is often diagnosed late, leading to a poor clinical outcome. Early diagnosis and timely management of renal complications can prevent the progression to end-stage renal disease.

Indexed as

Ciliary Motility DisordersKidney Diseases, CysticRetinitis PigmentosaAbnormalities, MultipleCerebellumCiliopathiesExome SequencingEye AbnormalitiesHumansLeber Congenital AmaurosisMaleMutationOptic Atrophies, HereditaryRetinaYoung AdultChronic kidney diseaseRetinal dystrophySenor–Løken syndrome

Identifiers

PMID41316455
PMCPMC12664155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.